Portfolio

Filter on

Investment Portfolio

16 companies
Ongoing
chroma
Sector:
Employees:

ChromaCure’s mission is to discover and develop first-in-class small molecule therapeutics for unmet needs in oncology.

Ongoing
EPICS Therapeutics
Sector:
Employees:

EPICS Therapeutics is a newly created company dedicated to develop novel therapeutic solutions for cancer, based on the highly innovative field of RNA epigenetics

Biotech
Exit
Ogeda logo
Sector: Biotech
Employees: 41

Clinical-stage drug discovery company that invents and develops small molecule drugs. It has been acquired by Astellas in 2017 for 800 M€ (publicly disclosed).

Biotech
Exit
Masthercell logo
Sector: Biotech
Employees: 73

Dynamic and global Contract Development and Manufacturing Organization for cell therapy companies. It has entered a share deal with Orgenesis in 2015.

Medtech
Ongoing
CluePoints logo
Sector: Medtech
Employees: 20

Offers a Risk-Based Monitoring software to improve data quality, increase operational efficiency and reduce regulatory submission risk, in clinical studies runned by pharma companies, CRO, CTO, …

Medtech
Ongoing
PharmaFluidics logo
Sector: Medtech
Employees: 4

Supplies micro-chip liquid chromatography cartridges designed for complex biological samples analysis and compatible with all standard nano-LC equipment.

ULB logo

ULB & THEODORUS

A 15 year-old partnership

How we build upon the ULB expertise

We are Theodorus,

THE ULB SPIN-OFF FUND
AND WE ARE LOOKING FORWARD
TO MEETING YOU!